Christopher Trummer
About Christopher Trummer
Christopher Trummer is a co-founder and entrepreneur with significant experience in biotechnology and health innovation. He has played a pivotal role in securing substantial funding and leading scientific teams in various organizations.
Work at Celeris Therapeutics
Christopher Trummer served as Co-founder, CEO, and President of Celeris Therapeutics from 2021 to 2024. During his tenure, he played a significant role in establishing an 800 sqm laboratory dedicated to synthetic chemistry and various biological aspects. He led a team of approximately 20 PhD scientists from renowned institutions, including Cambridge, Oxford, and Imperial College London. His contributions included critical peer-reviewed publications and inventions that advanced the company's research and development efforts.
Current Role at StartX
Since 2022, Christopher Trummer has been working as a Founder in the Fall '22 Med Cohort at StartX, located in Palo Alto, California. This role follows his previous experience in the biotech sector and reflects his ongoing commitment to innovation and entrepreneurship in the medical field. His involvement with StartX allows him to leverage his expertise and network to support emerging startups in the healthcare sector.
Education and Expertise
Christopher Trummer has a strong educational background in biotechnology and business informatics. He studied at Technische Universität Graz, where he earned a Bachelor of Science in Molecular Biology and a Diploma in Biotechnology from 2014 to 2017. He furthered his education at IU International University of Applied Sciences, obtaining a Master of Science in Business Informatics in 2020. This combination of scientific and business education underpins his expertise in the biotech industry.
Achievements in Equity Financing
Christopher Trummer achieved a notable milestone in Austrian finance by securing approximately EUR 20 million in committed capital, marking the largest EIC equity financing in the country's history. This accomplishment highlights his ability to attract significant investment and support for innovative projects within the biotech sector.
Board Membership at BIOTECH AUSTRIA
In 2023, Christopher Trummer was appointed as a Board Member at BIOTECH AUSTRIA. This position allows him to contribute to the strategic direction and development of the biotechnology sector in Austria, drawing on his extensive experience and knowledge in the field.